http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2427562

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Review
endingPage 70
issn 1744-7623
1472-8214
issueIdentifier 1
pageRange 59-70
publicationName Expert Opinion on Emerging Drugs
startingPage 59
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d0917f1a06e0097d1016e53130e39f59
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_185ff6afe94414af0fe3c2591a30b83e
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_afda781cb015dee18b326e8c2f403483
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5637ab8fc0c1fb482461488f39a4412e
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_877928a0ad7daf29f5450c0175c102e5
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_46d283bd2b42fb4a40078864cb391e7e
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d3e9cb2aa1e9fe8c426915758231ea2a
bibliographicCitation Azmi AS, Wang Z, Philip PA, Mohammad RM, Sarkar FH. Emerging Bcl-2 inhibitors for the treatment of cancer. Expert Opinion on Emerging Drugs. 2010 Sep 03;16(1):59–70. doi: 10.1517/14728214.2010.515210.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_999c9329e5861175069c7d1a25be7989
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1178-9505
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ae837bf734fc7c3e7a7b4b7e50ae641
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f12e794c90b0dad7f5da8cf5f43e376
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0855e1775477a611223d91e0626db67
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70f8ac9d2e8d5e287299101e89604576
date 2010-09-03^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC3084453
https://pubmed.ncbi.nlm.nih.gov/20812891
https://doi.org/10.1517/14728214.2010.515210
isPartOf https://portal.issn.org/resource/ISSN/1472-8214
https://portal.issn.org/resource/ISSN/1744-7623
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/31718
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Emerging Bcl-2 inhibitors for the treatment of cancer
discusses http://id.nlm.nih.gov/mesh/M0508295
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0028673
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D054852Q000627
http://id.nlm.nih.gov/mesh/D009369Q000188
http://id.nlm.nih.gov/mesh/D019253Q000037
http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D055808Q000379
hasSubjectTerm http://id.nlm.nih.gov/mesh/D002986
http://id.nlm.nih.gov/mesh/D017209Q000187
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D018572
http://id.nlm.nih.gov/mesh/D054852Q000008
http://id.nlm.nih.gov/mesh/D000970Q000008
http://id.nlm.nih.gov/mesh/D009369Q000378
http://id.nlm.nih.gov/mesh/D009369Q000473
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D054852Q000009
http://id.nlm.nih.gov/mesh/D000970Q000009
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4f3366af2ce1555e259faab86aad3bef
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0e75b04b99ad7f9547bbdf30bf933fe9
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Showing number of triples: 1 to 56 of 56.